@Max095 The share scares me 🙈🙈. The company has been profitable since 2023. In 2024, profit growth was in triple digits and the P/E ratio has fallen dramatically. The company has 6 well-performing drugs. And how has the share reacted to this? It has fallen extremely since 2023 and is now undervalued. And the chart doesn't show a bottom. What scares me is that I have no explanation for this strange reaction. And that's why I would be cautious. Because I find this kind of investor behavior very strange and would like to have it explained to me.